1. Home
  2. WMG vs BBIO Comparison

WMG vs BBIO Comparison

Compare WMG & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Warner Music Group Corp.

WMG

Warner Music Group Corp.

SELL

Current Price

$28.41

Market Cap

14.4B

ML Signal

SELL

Logo BridgeBio Pharma Inc.

BBIO

BridgeBio Pharma Inc.

HOLD

Current Price

$69.63

Market Cap

14.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WMG
BBIO
Founded
1929
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.4B
14.2B
IPO Year
2005
2019

Fundamental Metrics

Financial Performance
Metric
WMG
BBIO
Price
$28.41
$69.63
Analyst Decision
Buy
Strong Buy
Analyst Count
13
25
Target Price
$36.38
$86.04
AVG Volume (30 Days)
1.8M
1.7M
Earning Date
05-07-2026
04-29-2026
Dividend Yield
2.65%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,463,000,000.00
$502,076,000.00
Revenue This Year
$7.20
$89.45
Revenue Next Year
$5.99
$73.78
P/E Ratio
N/A
N/A
Revenue Growth
N/A
126.26
52 Week Low
$23.34
$31.77
52 Week High
$34.63
$84.94

Technical Indicators

Market Signals
Indicator
WMG
BBIO
Relative Strength Index (RSI) 53.81 40.40
Support Level $26.59 $61.95
Resistance Level $29.22 $78.96
Average True Range (ATR) 0.74 4.00
MACD -0.02 -0.72
Stochastic Oscillator 40.15 2.54

Price Performance

Historical Comparison
WMG
BBIO

About WMG Warner Music Group Corp.

Warner Music is the third-largest of the three major record companies. Recorded music accounts for most of the firm's revenue, with the segment housing notable record labels including Atlantic Records, Warner Records, Elektra Records. Some of the most successful current artists signed to record deals with Warner include Ed Sheeran, Bruno Mars, Cardi B, and Dua Lipa. Warner's remaining revenue comes from its publishing business, where Warner Chappell represents more than 180,000 songwriters and composers, some of whom are also Warner recording artists but many of whom are not recording artists or are attached to other labels. Warner Chappell controls more than 1 million musical compositions. Access Industries controls 98% of Warner's voting rights, while holding a 72% economic interest.

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

Share on Social Networks: